The involvement of leptin and adiponectin with receptors in the formation of many types of cancer as well as their impact on the clinical course of cancer patients are well established; however, the mechanisms of action of these adipokines are difficult to understand and thus need to be clarified. The gene discussed is LEP; the disease is cancer.